COMPOSITIONS AND METHODS FOR THE MODIFICATION OF GENE TRANSCRIPTION
Novel isolated polynucleotides that encode plant transcription factors are provided, together with genetic constructs comprising such polynucleotides. Methods for using such constructs in modulating the expression of endogenous and/or heterologous genes are also disclosed, together with transgenic plants comprising such constructs.
1 . An isolated polynucleotide comprising a sequence selected from the group consisting of: consisting of: SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421.
2 . An isolated polynucleotide comprising a sequence selected from the group consisting of:
(a) complements of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(b) reverse complements of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421; and
(c) reverse sequences a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421.
3 . An isolated polynucleotide comprising a sequence selected from the group consisting of:
(a) nucleotide sequences having at least 75% identity to a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(b) nucleotide sequences having at least 90% identity to a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(c) nucleotide sequence having at least 95% identity to a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(d) nucleotide sequences that hybridize to a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421 under stringent hybridization conditions;
(e) nucleotide sequences that are 200-mers of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(f) nucleotide sequences that are 100-mers of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421;
(g) nucleotide sequences that are 40-mers of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421; and
(h) nucleotide sequences that are 20-mers of a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421; and
(i) nucleotide sequences that are degeneratively equivalent to a sequence of SEQ ID NO: 1-591, 1183-1912, 1931-2106, 2371, 2374, 2377, 2385, 2387, 2389, 2391, 2393, 2395, 2397, 2399, 2401, 2403, 2405, 2407, 2409, 2411, 2413, 2415, 2417, 2419, and 2421,
wherein the isolated polynucleotide encodes a transcription factor.
4 . An oligonucleotide probe or primer comprising at least 10 contiguous residues complementary to 10 contiguous residues of a sequence of SEQ ID NO: 1-591, 1183-1912 and 1931-2106.
5 . An isolated polypeptide encoded by a polynucleotide according to any one of claims 1 - 3 .
6 . An isolated polypeptide comprising an amino acid sequence selected from the group consisting of: SEQ ID NO: 592, 594-850, 852-930, 932-951, 953-1046, 1048-1182, 1913-1930, 2107-2293, 2296-2368, 2372, 2375, 2378, 2386, 2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408, 2410, 2412, 2414, 2416, 2418, 2420, and 2422.
7 . An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
(a) sequences having at least 75% identity to a sequence of SEQ ID NO: 592, 594-850, 852-930, 932-951, 953-1046, 1048-1182, 1913-1930, 2107-2293, 2296-2368, 2372, 2375, 2378, 2386, 2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408, 2410, 2412, 2414, 2416, 2418, 2420, and 2422;
(b) sequences having at least 90% identity to a sequence of SEQ ID NO: 592, 594-850, 852-930, 932-951, 953-1046, 1048-1182, 1913-1930, 2107-2293, 2296-2368, 2372, 2375, 2378, 2386, 2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408, 2410, 2412, 2414, 2416, 2418, 2420, and 2422; and
(c) sequences having at least 95% identity to a sequence of SEQ ID NO: 592, 594-850, 852-930, 932-951, 953-1046, 1048-1182, 1913-1930, 2107-2293, 2296-2368, 2372, 2375, 2378, 2386, 2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408, 2410, 2412, 2414, 2416, 2418, 2420, and 2422,
wherein the isolated polypeptide functions as a transcription factor.
8 . An isolated polynucleotide that encodes a polypeptide according to any one of claims 6 and 7 .
9 . A genetic construct comprising a polynucleotide according to any one of claims 1 - 3 .
10 . A transgenic cell comprising a genetic construct according to claim 9 .
11 . A genetic construct comprising, in the 5′-3′ direction:
(a) a gene promoter sequence;
(b) a polynucleotide sequence comprising at least one of the following: (1) a polynucleotide coding for a polypeptide comprising a sequence of 592, 594-850, 852-930, 932-951, 953-1046, 1048-1182, 1913-1930, 2107-2293, 2296-2368, 2372, 2375, 2378, 2386, 2388, 2390, 2392, 2394, 2396, 2398, 2400, 2402, 2404, 2406, 2408, 2410, 2412, 2414, 2416, 2418, 2420, and 2422; and (2) a polynucleotide comprising a non-coding region of a polynucleotide of any one of claims 1 - 3 ; and
(c) a gene termination sequence.
12 . The genetic construct of claim 11 wherein the open reading frame is in a sense orientation.
13 . The genetic construct of claim 11 wherein the open reading frame is in an antisense orientation.
14 . A transgenic plant cell comprising a genetic construct of any one of claims 9 and 11 .
15 . A plant comprising a transgenic plant cell according to claim 14 , or fruit or seeds or propagules thereof.
16 . The plant of claim 15 wherein the plant is a woody plant.
17 . The plant of claim 16 wherein the plant is selected from the group consisting of eucalyptus, pine, acacia, poplar, sweetgum, teak and mahogany species
18 . A method for modifying gene expression in a plant comprising stably incorporating into the genome of the plant a genetic construct according to any one of claims 9 and 11 .
19 . The method of claim 18 , wherein the plant is a woody plant.
20 . The method of claim 18 , wherein the plant is selected from the group consisting of eucalyptus, pine, acacia, poplar, sweetgum, teak and mahogany species.
21 . A method for producing a plant having modified gene expression comprising:
(a) transforming a plant cell with a genetic construct according to any one of claims 9 and 11 to provide a transgenic cell; and
(b) cultivating the transgenic cell under conditions conducive to regeneration and mature plant growth.
22 . The method of claim 21 wherein the plant is a woody plant.
23 . The method of claim 21 wherein the plant is selected from the group consisting of eucalyptus, pine, acacia, poplar, sweetgum, teak and mahogany species.
24 . A method for modifying the activity of a polypeptide in a plant comprising stably incorporating into the genome of the plant a genetic construct according to any one of claims 9 and 11 .
25 . The method of claim 24 wherein the plant is a woody plant.
26 . The method of claim 24 wherein the plant is selected from the group consisting of eucalyptus, pine, acacia, poplar, sweetgum, teak and mahogany species.
27 . An isolated polypeptide comprising a DNA-binding domain, wherein the DNA-binding domain comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 2279-2293 and 2296-2368.